Volume 66, Issue 1, Pages (July 2004)

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Volume 68, Issue 5, Pages (November 2005)

Chronic Pain in End-Stage Renal Disease

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Volume 70, Pages S138-S145 (November 2006)

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

End-stage renal disease in developing countries

Volume 83, Issue 3, Pages (March 2013)

Volume 68, Issue 5, Pages (November 2005)

Volume 67, Issue 4, Pages (April 2005)

Kidney transplantation in a low-resource setting: Nigeria experience

Volume 61, Issue 2, Pages (February 2002)

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Insulin Resistance Is Associated With Circulating Fibrinogen Levels in Nondiabetic Patients Receiving Peritoneal Dialysis Cristina Martins, RD, PhD,

Burden of chronic kidney disease: North Africa

Francesco Paolo Schena Kidney International

Chronic Pain in End-Stage Renal Disease

Volume 54, Issue 4, Pages (October 1998)

End-stage renal disease in living kidney donors

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Comorbidity and confounding in end-stage renal disease

Volume 63, Issue 2, Pages (February 2003)

Volume 64, Issue 1, Pages (July 2003)

Volume 68, Issue 1, Pages (July 2005)

Volume 70, Issue 11, Pages (December 2006)

Volume 67, Issue 6, Pages (June 2005)

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Altered tryptophan metabolism and CKD-associated fatigue

Fructose intake as a risk factor for kidney stone disease

Response to ‘Hepcidin levels in patients with renal disease’

Volume 76, Issue 6, Pages (September 2009)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Future of icodextrin as an osmotic agent in peritoneal dialysis

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 74, Issue 5, Pages (September 2008)

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Peter Stenvinkel, Peter Barany, Olof Heimbürger, Roberto Pecoits-Filho,

Volume 81, Issue 9, Pages (May 2012)

Prehypertension: is it relevant for nephrologists?

Volume 87, Issue 5, Pages (May 2015)

Homocysteine, renal function, and risk of cardiovascular disease

Volume 65, Issue 1, Pages (January 2004)

Peritoneal dialysis in Mexico

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Low triiodothyronine and survival in end-stage renal disease

The Iranian model of living renal transplantation

Volume 80, Issue 10, Pages (November 2011)

Elevated plasma F2-isoprostanes in patients on long-term hemodialysis

Is complement a target for therapy in renal disease?

Volume 68, Issue 1, Pages (July 2005)

Volume 70, Issue 5, Pages (September 2006)

Volume 75, Issue 7, Pages (April 2009)

Volume 70, Issue 10, Pages (November 2006)

Familial phenotype differences in PKD11

Volume 57, Issue 4, Pages (April 2000)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund

Volume 76, Issue 2, Pages (July 2009)

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Volume 60, Issue 1, Pages (July 2001)

Volume 88, Issue 6, Pages (December 2015)

Presentation transcript:

Volume 66, Issue 1, Pages 46-50 (July 2004) Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease Alicia Marchlewska, Peter Stenvinkel, Bengt Lindholm, Anders Danielsson, Roberto Pecoits-Filho, Fredrik Lönnqvist, Martin Schalling, Olof Heimbürger, Louise Nordfors Kidney International Volume 66, Issue 1, Pages 46-50 (July 2004) DOI: 10.1111/j.1523-1755.2004.00705.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Box plot showing the difference in adiponectin (ApM1) gene expression between 18 ESRD patients and 9 healthy control patients (A). Box plot showing no significant difference in adiponectin (ApM1) gene expression between 9 ESRD patients with and 9 ESRD patients without MIA complications (B). Kidney International 2004 66, 46-50DOI: (10.1111/j.1523-1755.2004.00705.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Relation between adiponectin (ApM1) gene expression and plasma adiponectin levels in 6 ESRD patients. Kidney International 2004 66, 46-50DOI: (10.1111/j.1523-1755.2004.00705.x) Copyright © 2004 International Society of Nephrology Terms and Conditions